Pharmasset

Pharmasset Says Drug Trial Change Won’t Affect Gilead Takeover Agreement
Bloomberg
Fri, 12/16/11 - 11:26 am
Pharmasset
Gilead
M&A
hepatitis C
PSI-938
4 Reasons Inhibitex Is No Longer A Good Buy
Seeking Alpha
Wed, 12/7/11 - 11:42 am
Inhibitex
INX-189
Gilead
hepatitis C
Pharmasset
Pharmasset Poised to Pay 20% on Gilead Closing in First Quarter: Real M&A
Bloomberg
Mon, 12/5/11 - 10:14 pm
Pharmasset
Gilead
M&A
PSI-7977
hepatitis C
New Drug Approvals Make Or Break Biotechnology Stocks
Seeking Alpha
Wed, 11/30/11 - 10:46 am
Antares
Achillion
Pharmasset
Indenix
Inhibitex
ONYX Pharmaceuticals
Keryx
Gilead's Pharmasset Purchase Could Help Double Market Cap By 2020
Seeking Alpha
Mon, 11/28/11 - 11:38 am
Gilead
Pharmasset
M&A
hepatitis C
GSK
JNJ
Bristol-Myers Squibb
PSI-7977
Vertex
HIV
Gilead could have had Pharmasset cheap: founder
Reuters
Wed, 11/23/11 - 09:23 am
Pharmasset
Gilead
M&A
Pharmasset Shows Inhibitex-to-Achillion Drugmakers Up for Grabs: Real M&A
Bloomberg
Tue, 11/22/11 - 09:39 am
Inhibitex
Achillion
Pharmasset
Gilead
M&A
Gilead to Buy Pharmasset for $11B for Hepatitis C Treatments
Bloomberg
Mon, 11/21/11 - 09:44 am
Gilead
Pharmasset
hepatitis C
Healthcare Sector: Noteworthy Insider Buys And Sells
Seeking Alpha
Tue, 11/8/11 - 11:03 am
Alkermes
Bristol-Myers Squibb
Celgene
Gilead
Illumina
Inhibitex
JNJ
United Health
Seattle Genetics
Pharmasset
Pharmasset Rises After Hepatitis Drug Shows 100% Cure Rate
Bloomberg
Mon, 11/7/11 - 11:02 am
Pharmasset
hepatitis C
PSI-7977
Inhibitex Soars as Investors See Another Pharmasset in the Making
TheStreet.com
Fri, 11/4/11 - 09:29 am
Inhibitex
Pharmasset
INX-189
hepatitis C
PSI-7977
Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill
TheStreet.com
Tue, 11/1/11 - 09:01 am
Pharmasset
hepatitis C
Ribavirin
Vertex
Abbott Laboratories
PSI-7977
JNJ
Roche
Bristol-Myers Squibb
November Catalysts for Biotech and Drug Stocks
Minyanville
Mon, 10/31/11 - 11:34 am
FDA
Regeneron
Vertex
Pharmasset
pSivida
Alimera
Salix
Teva Pharmaceuticals
BioSante
Transcept
[video] The Next Big Thing in Biotech: Pharmasset
TheStreet.com
Fri, 10/28/11 - 11:25 am
hepatitis C
Pharmasset
PSI-7977
Vertex A Steal Based On Blockbuster Hepatitis C Drug Sales
Seeking Alpha
Fri, 10/28/11 - 09:34 am
Vertex
earnings
hepatitis C
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
SciClone
Pharmasset
Amgen Is Poised For Continued Success
Seeking Alpha
Wed, 10/26/11 - 09:08 am
Amgen
Pharmasset
Dendreon
Pharmasset Falls on Rival Abbott Hepatitis C Therapy Results
Reuters
Sat, 10/22/11 - 12:20 pm
Pharmasset
Abbott Laboratories
hepatitis C
ABT-450
protease inhibitors
ABT-333
ABT-072
Abbott May Be Doing The Right Thing At The Wrong Time
Seeking Alpha
Fri, 10/21/11 - 09:57 am
Abbott Laboratories
reorganization
Amgen
Biogen Idec
Bristol-Myers Squibb
GSK
JNJ
Boston Scientific
Medtronic
Pfizer
Roche
Pharmasset
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
TheStreet.com
Mon, 10/17/11 - 01:22 pm
Roche
M&A
Anadys
hepatitis C
Pegasys
setrobuvir
Merck
Victrelis
RG7128
Pharmasset
Pharmasset climbs after expanding study of hepatitis C drug for the second time
Yahoo/AP
Mon, 10/10/11 - 06:35 pm
Pharmasset
hepatitis C
PSI-7977

Pages